In the past week, SION stock has gone up by 12.09%, with a monthly gain of 23.29% and a quarterly surge of 32.56%. The volatility ratio for the week is 7.31%, and the volatility levels for the last 30 days are 6.62% for Sionna Therapeutics Inc The simple moving average for the past 20 days is 5.53% for SION’s stock, with a 12.71% simple moving average for the past 200 days.
Is It Worth Investing in Sionna Therapeutics Inc (NASDAQ: SION) Right Now?
There are mixed opinions on the stock, with 3 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for SION is 23.58M, and at present, short sellers hold a 12.18% of that float. The average trading volume of SION on June 25, 2025 was 149.73K shares.
SION) stock’s latest price update
Sionna Therapeutics Inc (NASDAQ: SION) has experienced a rise in its stock price by 119411 compared to its previous closing price of 14.1. However, the company has seen a gain of 12.09% in its stock price over the last five trading days. globenewswire.com reported 2025-06-06 that Data featured in oral presentation and poster session at 48 th European Cystic Fibrosis Conference
Analysts’ Opinion of SION
Stifel, on the other hand, stated in their research note that they expect to see SION reach a price target of $32. The rating they have provided for SION stocks is “Buy” according to the report published on March 04th, 2025.
Guggenheim gave a rating of “Buy” to SION, setting the target price at $45 in the report published on March 04th of the current year.
SION Trading at 19.58% from the 50-Day Moving Average
After a stumble in the market that brought SION to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -36.32% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SION starting from TPG GP A, LLC, who purchase 1,125,000 shares at the price of $18.00 back on Feb 10 ’25. After this action, TPG GP A, LLC now owns 6,684,962 shares of Sionna Therapeutics Inc, valued at $20,250,000 using the latest closing price.
RA CAPITAL MANAGEMENT, L.P., the Director of Sionna Therapeutics Inc, purchase 1,125,000 shares at $18.00 during a trade that took place back on Feb 10 ’25, which means that RA CAPITAL MANAGEMENT, L.P. is holding 6,923,365 shares at $20,250,000 based on the most recent closing price.
Stock Fundamentals for SION
The total capital return value is set at -0.18.
Based on Sionna Therapeutics Inc (SION), the company’s capital structure generated 0.03 points at debt to capital in total, while cash flow to debt ratio is standing at -5.13.
Currently, EBITDA for the company is -69.89 million with net debt to EBITDA at 1.17. The liquidity ratio also appears to be rather interesting for investors as it stands at 28.73.
Conclusion
In summary, Sionna Therapeutics Inc (SION) has had a better performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
